We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Bruker (BRKR) Up 17.1% Since Last Earnings Report: Can It Continue?
Read MoreHide Full Article
It has been about a month since the last earnings report for Bruker (BRKR - Free Report) . Shares have added about 17.1% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Bruker due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Bruker Corporation before we dive into how investors and analysts have reacted as of late.
Bruker's Q3 Earnings and Revenues Top Estimates
Bruker Corporation delivered adjusted earnings per share of 45 cents for the third quarter of 2025, down 25% year over year. However, the figure came 36.36% above the Zacks Consensus Estimate.
The adjustments include expenses related to the amortization of purchased intangibles, acquisition-related costs and restructuring costs, among others.
Third quarter 2025 GAAP diluted loss per share was 41 cents, compared to diluted earnings per share of 27 cents in the year-ago period.
BRKR’s Q3 Revenues
Bruker's third-quarter revenues were $860.5 million, down 0.5% year over year. However, the figure topped the Zacks Consensus Estimate by 1.20%.
BRKR’s 2025 Guidance
The company has lowered its financial guidance for full-year 2025. Revenues are now expected in the range of $3.41 to $3.44 billion (previously $3.43 to $3.50 billion), suggesting 1% to 2% reported growth over 2024. The Zacks Consensus Estimate for revenues is pegged at $3.42 billion.
Adjusted earnings per share for the year is expected in the range of $1.85 to $1.90 (previously $1.95 to $2.05). The consensus estimate for the same is pegged at $1.89.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates.
The consensus estimate has shifted -23% due to these changes.
VGM Scores
Currently, Bruker has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. Following the exact same course, the stock was allocated a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Bruker has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Bruker (BRKR) Up 17.1% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Bruker (BRKR - Free Report) . Shares have added about 17.1% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Bruker due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Bruker Corporation before we dive into how investors and analysts have reacted as of late.
Bruker's Q3 Earnings and Revenues Top Estimates
Bruker Corporation delivered adjusted earnings per share of 45 cents for the third quarter of 2025, down 25% year over year. However, the figure came 36.36% above the Zacks Consensus Estimate.
The adjustments include expenses related to the amortization of purchased intangibles, acquisition-related costs and restructuring costs, among others.
Third quarter 2025 GAAP diluted loss per share was 41 cents, compared to diluted earnings per share of 27 cents in the year-ago period.
BRKR’s Q3 Revenues
Bruker's third-quarter revenues were $860.5 million, down 0.5% year over year. However, the figure topped the Zacks Consensus Estimate by 1.20%.
BRKR’s 2025 Guidance
The company has lowered its financial guidance for full-year 2025. Revenues are now expected in the range of $3.41 to $3.44 billion (previously $3.43 to $3.50 billion), suggesting 1% to 2% reported growth over 2024. The Zacks Consensus Estimate for revenues is pegged at $3.42 billion.
Adjusted earnings per share for the year is expected in the range of $1.85 to $1.90 (previously $1.95 to $2.05). The consensus estimate for the same is pegged at $1.89.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates.
The consensus estimate has shifted -23% due to these changes.
VGM Scores
Currently, Bruker has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. Following the exact same course, the stock was allocated a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Bruker has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.